Evidence map›Paper›PMID 16731778›Full record

ArticleThe Journal of endocrinology2006

Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.

S-Y Chan, J A Franklyn, H N Pemberton, J N Bulmer, T J Visser, C J McCabe, M D Kilby

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of endocrinology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. β-Hydroxybutyrate Exposure is Associated with Increased THCellular and molecular neurobiology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Molecular pathways in placental-fetal development and disruption.Molecular and cellular endocrinology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Thyroid Hormone Transporters in Pregnancy and Fetal Development.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Thyroid Hormone Transporters in a Human Placental Cell Model.Thyroid : official journal of the American Thyroid Association · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

S-Y ChanDepartment of Fetal Medicine, Division of Reproductive & Child Health, University of Birmingham, Edgbaston, Birmingham B15 2TG, UK.
J A Franklyn
H N Pemberton
J N Bulmer
T J Visser
C J McCabe
M D Kilby
University of Birmingham · GBErasmus University Rotterdam · NLNewcastle University · GB

Funding

Medical Research Council G0501548Medical Research Council G0501548(76335)
6 · The paper itself

Abstract

Thyroid hormones (THs) are essential for normal fetal development, with even mild perturbation in maternal thyroid status in early pregnancy being associated with neurodevelopmental delay in children. Transplacental transfer of maternal THs is critical, with increasing evidence suggesting a role for 3,3',5-tri-iodothyronine (T3) in development and function of the placenta itself, as well as in development of the central nervous and other organ systems. Intrauterine growth restriction (IUGR) is associated with fetal hypothyroxinaemia, a factor that may contribute to neurodevelopmental delay. The recent description of monocarboxylate transporter 8 (MCT8) as a powerful and specific TH membrane transporter, and the association of MCT8 mutations with profound neurodevelopmental delay, led us to explore MCT8 expression in placenta. We describe the expression of MCT8 in normal human placenta throughout gestation, and in normal third-trimester placenta compared with that associated with IUGR using quantitative reverse transcriptase PCR. MCT8 mRNA was detected in placenta from early first trimester, with a significant increase with advancing gestation (P=0.007). In the early third trimester, MCT8 mRNA was increased in IUGR placenta compared with normal samples matched for gestational age (P<0.05), but there was no difference between IUGR and normal placenta in the late third trimester. Western immunoblotting findings in IUGR and normal placentae were in accord with mRNA data. MCT8 immunostaining was demonstrated in villous cytotrophoblast and syncytiotrophoblast as well as extravillous trophoblast cells from the first trimester onwards with increasingly widespread immunoreactivity seen with advancing gestation. In conclusion, expression of MCT8 in placenta from early gestation is compatible with an important role in TH transport during fetal development and a specific role in placental development. Altered expression in placenta associated with IUGR may reflect a compensatory mechanism attempting to increase T3 uptake by trophoblast cells.

Indexed as

AdultAnalysis of VarianceBlotting, WesternCase-Control StudiesExtraembryonic MembranesFemaleFetal Growth RetardationGestational AgeHumansImmunohistochemistryMonocarboxylic Acid TransportersPlacentaPregnancyPregnancy Trimester, ThirdReverse Transcriptase Polymerase Chain ReactionRNA, MessengerMonocarboxylic Acid TransportersRNA, MessengerSLC16A2 protein, humanSymportersThyroid Hormones

Identifiers

PMID16731778
PMCPMC2869027
OpenAlexW2126880712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.